equol has been researched along with liquiritigenin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JZ; Khan, MZI; Nazli, A; Uzair, M | 1 |
| Sareddy, GR; Vadlamudi, RK | 1 |
2 review(s) available for equol and liquiritigenin
| Article | Year |
|---|---|
An overview on Estrogen receptors signaling and its ligands in breast cancer.
Topics: Breast Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Ligands; Male; Receptors, Estrogen | 2022 |
Cancer therapy using natural ligands that target estrogen receptor beta.
Topics: Antineoplastic Agents, Phytogenic; Equol; Estrogen Receptor beta; Flavanones; Genistein; Glycine max; Glycyrrhiza; Humans; Ligands; Neoplasms; Phytotherapy; Plant Extracts | 2015 |